PT - JOURNAL ARTICLE AU - Sudha Sundar AU - Ranjit Manchanda AU - Charlie Gourley AU - Angela George AU - Andrew Wallace AU - Janos Balega AU - Sarah Williams AU - Yvonne Wallis AU - Richard Edmondson AU - Shibani Nicum AU - Jonathan Frost AU - Ayoma Attygalle AU - Christina Fotopoulou AU - Rebecca Bowen AU - Dani Bell AU - Ketankumar Gajjar AU - Bruce Ramsay AU - Nicholas J Wood AU - Sadaf Ghaem-Maghami AU - Tracie Miles AU - Raji Ganesan TI - British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for <em>BRCA</em>1/2 variants in ovarian cancer in the United Kingdom AID - 10.1136/ijgc-2020-002112 DP - 2021 Feb 01 TA - International Journal of Gynecologic Cancer PG - 272--278 VI - 31 IP - 2 4099 - http://ijgc.bmj.com/content/31/2/272.short 4100 - http://ijgc.bmj.com/content/31/2/272.full SO - Int J Gynecol Cancer2021 Feb 01; 31 AB - The British Gynecological Cancer Society and the British Association of Gynecological Pathologists established a multidisciplinary consensus group comprising experts in surgical gynecological oncology, medical oncology, genetics, and laboratory science, and clinical nurse specialists to identify the optimal pathways to BRCA germline and tumor testing in patients with ovarian cancer in routine clinical practice. In particular, the group explored models of consent, quality standards identified at pathology laboratories, and experience and data from pioneering cancer centers. The group liaised with representatives from ovarian cancer charities to also identify patient perspectives that would be important to implementation. Recommendations from these consensus group deliberations are presented in this manuscript.